Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy-Reference-Cited by-同舟云学术

Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy

Published:2021-06 Issue: Volume:421 Page:115534
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Best Rebecca L.,LaPointe Nichole E.,Azarenko Olga,Miller Herb,Genualdi Christine,Chih Stephen,Shen Ben-Quan,Jordan Mary Ann,Wilson Leslie,Feinstein Stuart C.,Stagg Nicola J.

Funder

Genentech Inc

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference73 articles.

1. Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation;Alday;Biochemistry,2009

2. Microtubule dynamics in the peripheral nervous system: A matter of balance;Almeida-Souza;Bioarchitecture,2011

3. How Taxol stabilises microtubule structure;Amos;Chem. Biol.,1999

4. Epothilone-induced peripheral neuropathy: a review of current knowledge;Argyriou;J. Pain Symptom Manag.,2011

5. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update;Argyriou;Crit. Rev. Oncol. Hematol.,2012

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance study of the association between peripheral neuropathy and antibody–drug conjugates using the FDA adverse event reporting system;Scientific Reports;2024-09-13

2. First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors;npj Precision Oncology;2024-09-12

3. T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers;Molecular Therapy: Oncology;2024-09

4. Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in the Frontline Treatment of Classical Hodgkin Lymphoma;Critical Reviews in Oncology/Hematology;2024-09

5. Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database;Frontiers in Immunology;2024-08-20